Mich. Admin. Code R. 336.1233 - Methodology for determining initial threshold screening levels based on acute data

Rule 233.

(1) An ITSL based on acute data shall be determined by either of the following:

From short-term studies, as follow:

Click Here To View Image

Where:

POD = Point of Departure

UFh = a value from 1 to 10 for average human to sensitive human extrapolation

UF_A = a value from 1 to 10 for animal to human extrapolation

UF_L = a value from 1 to 10 for LOAEL to NOAEL extrapolation

AT = Averaging time of 1, 8 or 24 hours

The POD is defined as the human equivalent concentration of any of the following:

NOAEL = no observed adverse effect level

LOAEL = lowest observed adverse effect level

BMDL = 95% lower confidence limit on the benchmark dose (BMD)

BMCL = 95% lower confidence limit on the benchmark concentration (BMC)

The BMD or BMC value is derived according to the United States environmental protection agency benchmark dose technical guidance, adopted by reference in R 336.1902. "Human equivalent concentration" is defined as an exposure concentration for humans that has been adjusted for dosimetric differences between experimental animal species and humans to be equivalent to the exposure concentration associated with observed effects in the experimental animal species. If occupational human exposures are used for extrapolation, the human equivalent concentration represents the equivalent human exposure concentration adjusted to a continuous basis.

(b) The ITSL may be determined on a case-by-case basis using a POD from repeated dose studies using any alternative methodology to assess acute health effects that can be demonstrated to the department to be more appropriate based on toxicological grounds and that is supported by the scientific data.

(2) The averaging times to be used for an acute ITSL will be 1, 8, or 24 hours, as appropriate based on the data.

Notes

Mich. Admin. Code R. 336.1233

2016 MR 24, Eff. 12/27/2016